CorMedix (CRMD) Share-based Compensation Growth (3y) (2015 - 2025)
CorMedix (CRMD) Share-based Compensation Growth (3y) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Stock Comp. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
4.80% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
10.78% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
CorMedix |
631,378.03 |
-154.57 Mn |
107.31 Mn |
60.13% |
| Date | Value |
|---|
| Dec 31, 2025 |
60.13% |
| Sep 30, 2025 |
65.61% |
| Jun 30, 2025 |
276.90% |
| Mar 31, 2025 |
45.42% |
| Dec 31, 2024 |
-1.62% |
| Sep 30, 2024 |
5.41% |
| Jun 30, 2024 |
7.76% |
| Mar 31, 2024 |
12.17% |
| Dec 31, 2023 |
33.11% |
| Sep 30, 2023 |
15.82% |
| Jun 30, 2023 |
12.45% |
| Mar 31, 2023 |
48.51% |
| Dec 31, 2022 |
24.46% |
| Sep 30, 2022 |
14.71% |
| Jun 30, 2022 |
-55.22% |
| Mar 31, 2022 |
12.04% |
| Dec 31, 2021 |
441.36% |
| Sep 30, 2021 |
45.68% |
| Jun 30, 2021 |
44.18% |
| Mar 31, 2021 |
70.40% |
